MedCath swoons on lowered ’08 and Q2 lowered outlook
Shares of MedCath Corp. (Nasdaq: MDTH) are taking it in the chin out of the gate after the healthcare provider this morning lowered its fiscal year and fiscal second-quarter revenue and earnings projections below the consensus on Wall Street. The company attributed the downward revisions to a shift in product and payer mix during the second quarter and cost report settlements incurred in a prior period, which reduced preliminary net revenue.
Shares gained 10.6%, or $0.57, to $5.95 ahead of the bell. For detailed price information and recent news stories about MedCath, click MDTH.
For access to the full article, you must be a registered member - it's FREE.
Already a member? Please log in below
Not Registered?
Register today and enjoy all that SmallCapInvestor.com has to offer, including:
- Daily small cap stock profiles.
- Intra-day coverage of Russell 2000 companies.
- Research and insights from our analysts.
- Special reports.
